T
About
Singular Genomics is a life sciences technology company that has developed the G4X™ Spatial Sequencing Platform — a next-generation, high-throughput in situ multiomics solution built for clinical and translational research. The platform simultaneously captures transcriptomics (up to 500-plex RNA), proteomics (18-plex protein), and fluorescent H&E (fH&E) imaging from the same FFPE tissue section at subcellular resolution, enabling a truly integrated multiomic view of complex biological systems. G4X is designed for population-scale studies, allowing research institutions and clinical labs to rapidly and cost-effectively process large retrospective cohorts of clinical samples. Its exceptional throughput makes it practical to support large consortia, clinical trials, and AI-driven translational projects without being constrained by bandwidth or cost. The platform also doubles as a fast, flexible next-generation sequencing (NGS) instrument for applications beyond spatial biology. With the ability to reconstruct 3D molecular landscapes — such as profiling millions of single cells across multiple tissue sections in a single flow cell run — G4X is powering breakthroughs in oncology, immunology, and pathology. Adopted by leading academic medical centers including Harvard, Vanderbilt, and Beth Israel Deaconess, the platform is purpose-built for scientists tackling the most complex questions in precision medicine and spatial pathology.
Key Features
- Multiomic In Situ Profiling: Simultaneously measures up to 500-plex RNA, 18-plex protein, and fH&E from a single FFPE tissue section at subcellular resolution.
- Population-Scale Throughput: Processes large retrospective clinical cohorts rapidly and cost-effectively, enabling studies previously impossible due to time or resource constraints.
- 3D Biological Reconstruction: Supports large-scale 3D molecular studies by stacking serial tissue sections, allowing reconstruction of full organ or tumor microenvironments with millions of single cells.
- AI-Enabled Translational Insights: Integrates AI-driven analysis workflows to extract actionable biological and clinical insights from complex spatial multiomics data.
- Dual-Use NGS Platform: Beyond spatial biology, G4X functions as a fast and flexible next-generation sequencing platform for a broad range of genomics applications.
Use Cases
- Profiling the tumor microenvironment in large oncology cohorts to identify biomarkers for precision cancer therapies
- Generating 3D spatial molecular atlases of tissues by stacking serial FFPE sections for comprehensive structural and cellular mapping
- Supporting large-scale clinical trials and consortia with cost-effective, high-throughput spatial tissue profiling
- Combining transcriptomic and proteomic data to characterize immune cell states in complex diseases such as AML and solid tumors
- Enabling AI-powered spatial pathology workflows that integrate multiomics data with histological imaging for next-generation diagnostics
Pros
- Unmatched Throughput for Clinical Cohorts: G4X enables processing of hundreds of samples across diverse tissue types and quality levels, making large-scale clinical trials and consortia studies feasible.
- True Multiomics in One Workflow: Combining RNA, protein, and histology in a single assay reduces sample consumption, workflow complexity, and data integration challenges.
- Validated in Challenging Sample Types: Demonstrated high-quality data from notoriously difficult samples like bone marrow FFPE, expanding applicability across diverse research areas.
Cons
- Enterprise-Level Cost: As a specialized scientific instrument platform, G4X requires significant capital investment, limiting accessibility to well-funded labs and institutions.
- Steep Learning Curve: The multiomic workflow and downstream AI analysis ecosystem may require specialized bioinformatics expertise to fully leverage.
- Hardware Dependency: The platform is tied to proprietary G4X instrumentation, making it inaccessible without on-site hardware or a service partnership.
Frequently Asked Questions
What is the G4X™ platform?
G4X™ is Singular Genomics' high-throughput spatial sequencing platform that enables simultaneous measurement of RNA (up to 500-plex), protein (18-plex), and fH&E imaging in FFPE tissue sections at subcellular resolution.
What sample types does G4X support?
G4X is validated across a wide range of FFPE tissue types, including notoriously difficult samples such as bone marrow, as well as head and neck cancer, kidney cancer, and other solid tumor types.
Can G4X be used for NGS beyond spatial biology?
Yes. G4X doubles as a fast, flexible next-generation sequencing platform, allowing labs to utilize the instrument for standard genomics workflows in addition to spatial multiomics.
How does G4X support AI-driven research?
The platform generates high-dimensional spatial multiomics datasets at scale that feed directly into AI and machine learning analysis pipelines, enabling translational insights for precision diagnostics and personalized medicine.
Who are the primary users of Singular Genomics G4X?
G4X is designed for academic medical centers, cancer research institutes, clinical pathology labs, and translational research teams working on large-scale patient cohorts and precision medicine initiatives.
